Pres. Trump Announces Nine New Pharmaceutical Companies Offering Massive U.S. Discounts - 08/31/26

The administration has expanded its \"Most Favored Nation\" drug pricing initiative, securing agreements with 26 pharmaceutical companies—representing 90% of the domestic market. This policy shifts the U.S. from paying the highest global drug prices to the lowest, aiming to save Americans over $600 billion by aligning domestic costs with the lowest international rates.